24 results
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
28 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:29pm
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
9:29pm
8-K
EX-3.2
ZVRA
Zevra Therapeutics Inc
23 Feb 23
Amendments to Articles of Incorporation or Bylaws
9:29pm
8-K
EX-3.1
ZVRA
Zevra Therapeutics Inc
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.2
ZVRA
Zevra Therapeutics Inc
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.3
8ch1e4 7vb3
23 Jun 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-3.1
jn8qbdnl
13 Jan 21
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
12:00am
8-K
EX-3.1
upi s7xjvvtjlvj4
28 Dec 20
KemPharm Announces 1-for-16 Reverse Stock Split
12:00am
8-K
EX-3.1
fb2p0p9 w9s
21 Dec 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-3.1
jgo6 s8v03l7bb71gt
18 Dec 19
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital
7:30am
8-K
EX-3.2
bepmg
4 Sep 19
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales
8:01am
8-K
EX-3.1
evtacgbkej28z8y
4 Sep 19
Up to a Total of $493 Million in Upfront, Sales and Development Milestone Payments, as well as Royalties on Net Sales
8:01am
8-K
EX-3.1
h6hjr7
5 Oct 18
KemPharm Announces Pricing of Public Offering of Common Stock
10:03am
8-K
EX-3.1
7ca342 lwudfv2q6zr
21 Apr 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.2
bzgz apo8wwdh0x7
21 Apr 15
Amendments to Articles of Incorporation or Bylaws
12:00am
S-1/A
EX-3.2
twh3lz8rh9u8194s14s2
3 Apr 15
IPO registration (amended)
12:00am
S-1
EX-3.1
z7ekwi8e
11 Mar 15
IPO registration
12:00am
S-1
EX-3.3
xvq zy0vy3495zit6gsp
11 Mar 15
IPO registration
12:00am
S-1
EX-3.4
qz1bf5s he0k
11 Mar 15
IPO registration
12:00am